Medibio Limited (MDBIF)
USD 0.01
(0.0%)
USD 0.01
(0.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 | - AUD | -100.0% |
| 2023 | 22.07 Thousand AUD | -44.87% |
| 2022 | 40.03 Thousand AUD | -60.61% |
| 2021 | 101.65 Thousand AUD | -23.85% |
| 2020 | 133.5 Thousand AUD | -63.39% |
| 2019 | 364.62 Thousand AUD | 77.97% |
| 2018 | 204.87 Thousand AUD | 786.92% |
| 2017 | 23.1 Thousand AUD | 24.86% |
| 2016 | 18.5 Thousand AUD | -92.75% |
| 2015 | 255.12 Thousand AUD | 0.0% |
| 2014 | - AUD | -100.0% |
| 2013 | 19.23 Thousand AUD | -63.3% |
| 2012 | 52.39 Thousand AUD | -82.18% |
| 2011 | 294.04 Thousand AUD | 20095.19% |
| 2010 | 1456.00 AUD | 0.0% |
| 2009 | - AUD | 0.0% |
| 2008 | - AUD | -100.0% |
| 2007 | 8356.00 AUD | -51.3% |
| 2006 | 17.15 Thousand AUD | -84.82% |
| 2005 | 113.05 Thousand AUD | 207.59% |
| 2004 | 36.75 Thousand AUD | -36.18% |
| 2003 | 57.59 Thousand AUD | -62.85% |
| 2002 | 155 Thousand AUD | 10.15% |
| 2001 | 140.71 Thousand AUD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 FY | - AUD | -100.0% |
| 2024 Q1 | 9566.00 AUD | 3164.85% |
| 2024 Q4 | - AUD | 0.0% |
| 2024 Q2 | 9566.00 AUD | 0.0% |
| 2023 Q3 | 147.00 AUD | -99.33% |
| 2023 Q1 | 480.07 Thousand AUD | 1700.61% |
| 2023 FY | 22.07 Thousand AUD | -44.87% |
| 2023 Q4 | 293.00 AUD | 99.32% |
| 2023 Q2 | 21.78 Thousand AUD | -95.46% |
| 2022 Q1 | 489.45 Thousand AUD | 2250.68% |
| 2022 Q2 | 13.37 Thousand AUD | -97.27% |
| 2022 Q3 | 13.26 Thousand AUD | -0.81% |
| 2022 FY | 40.03 Thousand AUD | -60.61% |
| 2022 Q4 | 26.66 Thousand AUD | 100.96% |
| 2021 FY | 101.65 Thousand AUD | -23.85% |
| 2021 Q1 | 504.01 Thousand AUD | 726.25% |
| 2021 Q4 | 20.82 Thousand AUD | -83.7% |
| 2021 Q3 | 127.76 Thousand AUD | 58.05% |
| 2021 Q2 | 80.83 Thousand AUD | -83.96% |
| 2020 FY | 133.5 Thousand AUD | -63.39% |
| 2020 Q2 | 72.5 Thousand AUD | -81.58% |
| 2020 Q3 | 69.04 Thousand AUD | -4.76% |
| 2020 Q4 | 61 Thousand AUD | -11.65% |
| 2020 Q1 | 393.58 Thousand AUD | 245.48% |
| 2019 Q3 | 343.22 Thousand AUD | -79.9% |
| 2019 FY | 364.62 Thousand AUD | 77.97% |
| 2019 Q1 | 1.7 Million AUD | 684.49% |
| 2019 Q4 | 113.92 Thousand AUD | -66.81% |
| 2019 Q2 | 1.7 Million AUD | 0.0% |
| 2018 Q2 | 1.52 Million AUD | 0.0% |
| 2018 Q1 | 1.52 Million AUD | 6233.67% |
| 2018 FY | 204.87 Thousand AUD | 786.92% |
| 2018 Q4 | -292.2 Thousand AUD | 0.0% |
| 2018 Q3 | -292.2 Thousand AUD | -119.18% |
| 2017 Q3 | 24.05 Thousand AUD | -98.44% |
| 2017 FY | 23.1 Thousand AUD | 24.86% |
| 2017 Q4 | 24.05 Thousand AUD | 0.0% |
| 2017 Q1 | 1.53 Million AUD | 488.37% |
| 2017 Q2 | 1.53 Million AUD | 0.0% |
| 2016 Q3 | 261.25 Thousand AUD | -57.68% |
| 2016 FY | 18.5 Thousand AUD | -92.75% |
| 2016 Q4 | 261.25 Thousand AUD | 0.0% |
| 2016 Q1 | 617.31 Thousand AUD | 383.94% |
| 2016 Q2 | 617.31 Thousand AUD | 0.0% |
| 2015 FY | 255.12 Thousand AUD | 0.0% |
| 2015 Q1 | - AUD | 100.0% |
| 2015 Q2 | - AUD | 0.0% |
| 2015 Q4 | 127.56 Thousand AUD | 0.0% |
| 2015 Q3 | 127.56 Thousand AUD | 0.0% |
| 2014 Q4 | -234.59 Thousand AUD | 0.0% |
| 2014 Q2 | 234.59 Thousand AUD | 0.0% |
| 2014 Q3 | -234.59 Thousand AUD | -200.0% |
| 2014 Q1 | 234.59 Thousand AUD | 9336.06% |
| 2014 FY | - AUD | -100.0% |
| 2013 Q4 | -2540.00 AUD | 0.0% |
| 2013 Q3 | -2540.00 AUD | 0.0% |
| 2013 FY | 19.23 Thousand AUD | -63.3% |
| 2012 FY | 52.39 Thousand AUD | -82.18% |
| 2011 FY | 294.04 Thousand AUD | 20095.19% |
| 2010 FY | 1456.00 AUD | 0.0% |
| 2009 FY | - AUD | 0.0% |
| 2008 FY | - AUD | -100.0% |
| 2007 FY | 8356.00 AUD | -51.3% |
| 2006 FY | 17.15 Thousand AUD | -84.82% |
| 2005 FY | 113.05 Thousand AUD | 207.59% |
| 2004 FY | 36.75 Thousand AUD | -36.18% |
| 2003 FY | 57.59 Thousand AUD | -62.85% |
| 2002 FY | 155 Thousand AUD | 10.15% |
| 2001 FY | 140.71 Thousand AUD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Achiko AG | 62.5 Thousand USD | 100.0% |
| Accelera Innovations, Inc | - USD | NaN% |
| Aspyra Inc. | 8.52 Million USD | 100.0% |
| Cannabis Sativa, Inc. | 1.17 Million USD | 100.0% |
| CompuMed, Inc. | 5.83 Million USD | 100.0% |
| CompuGroup Medical SE & Co. KGaA | 1.31 Billion USD | 100.0% |
| Cogstate Limited | 43.42 Million USD | 100.0% |
| CareView Communications, Inc. | 9.68 Million USD | 100.0% |
| Craneware plc | 189.26 Million USD | 100.0% |
| Caduceus Software Systems Corp. | 6.58 Million USD | 100.0% |
| Certive Solutions Inc. | 1.27 Million USD | 100.0% |
| Drug Free Solution, Inc. | 805.00 USD | 100.0% |
| DATATRAK International, Inc. | 6.18 Million USD | 100.0% |
| Strainsforpains, Inc. | 84.11 Thousand USD | 100.0% |
| Healixa Inc. | 598.88 Thousand USD | 100.0% |
| Easy Technologies Inc. | - USD | NaN% |
| eWellness Healthcare Corporation | - USD | NaN% |
| Founders Bay Holdings | 16.45 Million USD | 100.0% |
| Health Discovery Corporation | - USD | NaN% |
| Healthcare Integrated Technologies, Inc. | 322 Thousand USD | 100.0% |
| H-Source Holdings Ltd. | - USD | NaN% |
| InterCare DX, Inc. | - USD | NaN% |
| iCoreConnect Inc. | 8.15 Million USD | 100.0% |
| IQ-AI Limited | 775.75 Thousand USD | 100.0% |
| Cannabiz Mobile, Inc. | - USD | NaN% |
| Mednow Inc. | 12.99 Million USD | 100.0% |
| Galileo Life Sciences, Inc. | - USD | NaN% |
| MediXall Group, Inc. | 59.26 Thousand USD | 100.0% |
| Mitesco, Inc. | - USD | NaN% |
| MobileSmith, Inc. | 1.57 Million USD | 100.0% |
| NantHealth, Inc. | 67 Million USD | 100.0% |
| Net Medical Xpress Solutions, Inc. | 597 Thousand USD | 100.0% |
| OneLife Technologies Corp. | - USD | NaN% |
| ORHub, Inc. | 324.86 Thousand USD | 100.0% |
| Patient Access Solutions, Inc. | 212.73 Thousand USD | 100.0% |
| Pharma-Bio Serv, Inc. | 16.97 Million USD | 100.0% |
| PPJ Healthcare Enterprises, Inc. | 711.03 Thousand USD | 100.0% |
| Medical Cannabis Payment Solutions, Inc. | - USD | NaN% |
| Renalytix Plc | 2.28 Million USD | 100.0% |
| Revium Recovery Inc. | - USD | NaN% |
| RYAH Group, Inc. | - USD | NaN% |
| Carepay Inc. | 1.46 Million USD | 100.0% |
| Vaso Corporation | 81.02 Million USD | 100.0% |
| Vynleads, Inc. | - USD | NaN% |